Literature DB >> 19637074

The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders.

Elias Dakwar1, Frances R Levin.   

Abstract

Over the past 30 years the practice of meditation has become increasingly popular in clinical settings. In addition to evidence-based medical uses, meditation may have psychiatric benefits. In this review, the literature on the role of meditation in addressing psychiatric issues, and specifically substance use disorders, is discussed. Each of the three meditation modalities that have been most widely studied-transcendental meditation, Buddhist meditation, and mindfulness-based meditation-is critically examined in terms of its background, techniques, mechanisms of action, and evidence-based clinical applications, with special attention given to its emerging role in the treatment of substance use disorders. The unique methodological difficulties that beset the study of meditation are also considered. A brief discussion then integrates the research that has been completed thus far, elucidates the specific ways that meditation may be helpful for substance use disorders, and suggests new avenues for research.

Entities:  

Mesh:

Year:  2009        PMID: 19637074      PMCID: PMC3109319          DOI: 10.1080/10673220903149135

Source DB:  PubMed          Journal:  Harv Rev Psychiatry        ISSN: 1067-3229            Impact factor:   3.732


  65 in total

1.  Concentration and mindfulness meditations: unique forms of consciousness?

Authors:  B R Dunn; J A Hartigan; W L Mikulas
Journal:  Appl Psychophysiol Biofeedback       Date:  1999-09

2.  Gamma, alpha, delta, and theta oscillations govern cognitive processes.

Authors:  E Başar; C Başar-Eroglu; S Karakaş; M Schürmann
Journal:  Int J Psychophysiol       Date:  2001-01       Impact factor: 2.997

3.  Cerebral blood flow during meditative prayer: preliminary findings and methodological issues.

Authors:  Andrew Newberg; Michael Pourdehnad; Abass Alavi; Eugene G d'Aquili
Journal:  Percept Mot Skills       Date:  2003-10

4.  Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.

Authors:  Maura Paul-Labrador; Donna Polk; James H Dwyer; Ivan Velasquez; Sanford Nidich; Maxwell Rainforth; Robert Schneider; C Noel Bairey Merz
Journal:  Arch Intern Med       Date:  2006-06-12

5.  Yoga Asana sessions increase brain GABA levels: a pilot study.

Authors:  Chris C Streeter; J Eric Jensen; Ruth M Perlmutter; Howard J Cabral; Hua Tian; Devin B Terhune; Domenic A Ciraulo; Perry F Renshaw
Journal:  J Altern Complement Med       Date:  2007-05       Impact factor: 2.579

6.  Effects on regional cerebral blood flow of transcendental meditation.

Authors:  R Jevning; R Anand; M Biedebach; G Fernando
Journal:  Physiol Behav       Date:  1996-03

7.  Transcendental meditation, mindfulness, and longevity: an experimental study with the elderly.

Authors:  C N Alexander; E J Langer; R I Newman; H M Chandler; J L Davies
Journal:  J Pers Soc Psychol       Date:  1989-12

8.  A wakeful hypometabolic physiologic state.

Authors:  R K Wallace; H Benson; A F Wilson
Journal:  Am J Physiol       Date:  1971-09

9.  The transcendental meditation program's effect on addictive behavior.

Authors:  A Aron; E N Aron
Journal:  Addict Behav       Date:  1980       Impact factor: 3.913

10.  Individuals with mental illness can control their aggressive behavior through mindfulness training.

Authors:  Nirbhay N Singh; Giulio E Lancioni; Alan S W Winton; Angela D Adkins; Robert G Wahler; Mohamed Sabaawi; Judy Singh
Journal:  Behav Modif       Date:  2007-05
View more
  12 in total

1.  Mindfulness-based cognitive therapy improves emotional reactivity to social stress: results from a randomized controlled trial.

Authors:  Willoughby B Britton; Ben Shahar; Ohad Szepsenwol; W Jake Jacobs
Journal:  Behav Ther       Date:  2011-10-01

2.  Evaluation of Yoga for Preventing Adolescent Substance Use Risk Factors in a Middle School Setting: A Preliminary Group-Randomized Controlled Trial.

Authors:  Bethany Butzer; Amanda LoRusso; Sunny H Shin; Sat Bir S Khalsa
Journal:  J Youth Adolesc       Date:  2016-05-31

Review 3.  Meditative therapies for reducing anxiety: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Kevin W Chen; Christine C Berger; Eric Manheimer; Darlene Forde; Jessica Magidson; Laya Dachman; C W Lejuez
Journal:  Depress Anxiety       Date:  2012-06-14       Impact factor: 6.505

4.  Mindfulness impairments in individuals seeking treatment for substance use disorders.

Authors:  Elias Dakwar; John P Mariani; Frances R Levin
Journal:  Am J Drug Alcohol Abuse       Date:  2011-03-17       Impact factor: 3.829

5.  When conventional medical providers recommend unconventional medicine: results of a national study.

Authors:  Aditi Nerurkar; Gloria Yeh; Roger B Davis; Gurjeet Birdee; Russell S Phillips
Journal:  Arch Intern Med       Date:  2011-05-09

6.  Open Mind, Open Heart: An Anthropological Study of the Therapeutics of Meditation Practice in the US.

Authors:  Neely Myers; Sara Lewis; Mary Ann Dutton
Journal:  Cult Med Psychiatry       Date:  2015-09

7.  Mindfulness-Based Stress Reduction for Low-Income, Predominantly African American Women With PTSD and a History of Intimate Partner Violence.

Authors:  Mary Ann Dutton; Diana Bermudez; Armely Matas; Haseeb Majid; Neely L Myers
Journal:  Cogn Behav Pract       Date:  2013-02-01

Review 8.  A narrative review of yoga and mindfulness as complementary therapies for addiction.

Authors:  Surbhi Khanna; Jeffrey M Greeson
Journal:  Complement Ther Med       Date:  2013-02-23       Impact factor: 2.446

9.  Individual mindfulness-based psychotherapy for cannabis or cocaine dependence: a pilot feasibility trial.

Authors:  Elias Dakwar; Frances R Levin
Journal:  Am J Addict       Date:  2013-08-30

10.  Mindfulness and Behavior Change.

Authors:  Zev Schuman-Olivier; Marcelo Trombka; David A Lovas; Judson A Brewer; David R Vago; Richa Gawande; Julie P Dunne; Sara W Lazar; Eric B Loucks; Carl Fulwiler
Journal:  Harv Rev Psychiatry       Date:  2020 Nov/Dec       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.